CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. vs. AstraZeneca AB

Explore the PTAB proceeding IPR2016-01324 filed by Mylan Pharmaceuticals Inc. on 2016-06-29. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01324

Filing Date

2016-06-29

Accorded Filing Date

2016-06-29

Institution Decision Date

โ€”

Last Modified Date

2017-01-30

Proceeding Type

IPR

Termination Date

2017-01-10

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Patent Owner / Respondent

AstraZeneca AB

Represented By

Filko Prugo

Patent Information

1 Patent Involved
Respondent Application Number 10872784
Respondent Patent Number 7456160
Legal Expiration Date
2023-06-01 Expired (Term Ended)
Injunction Viability (35 U.S.C. ยง 283) Statutorily Barred
Respondent Inventor John R. Evans et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Terminated-Settled

Board Decisions & Rulings (1)

Settlement before Institution 2017-01-10
Termination - Settled Before Institution
37 CFR 42.72, 37 CFR 42.74, 35 USC 317

Address and Attorney/Agent Information

98 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Morgan, Lewis & Bockius LLP (WA)
Customer Number 9629
Address 1111 Pennsylvania Avenue, N.W., Washington, DC, 20004, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
31066 Gary Williams +1 650-843-7501
37386 Michael Lyons +1 650-843-7507
39266 Soyeon Laub +1 714-830-0512
39951 Douglas Crisman +1 650-843-4000
40506 Louis Beardell Jr +1 215-963-5067
41040 Robert Goodell +1 202-739-5549
41796 Andrew Gray Iv +1 650-843-4000
42223 Jason White +1 312-321-4200

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 4 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 9 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): GB ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (13 found):
PTAB: 9 U.S. Courts: 4
USPTO PTAB Trial 2017-08-04
IPR2017-01912

FRESENIUS KABI USA, LLC v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Institution Denied
USPTO PTAB Trial 2017-08-04
IPR2017-01910

Fresenius Kabi USA,LLC v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2017-08-04
IPR2017-01913

Fresenius Kabi USA, LLC v. AstraZeneca AB

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00900

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00905

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00904

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2016-06-29
IPR2016-01325

Mylan Pharmaceuticals Inc. et al. v. AstraZeneca AB et al.

U.S. Continuation Sibling (8329680)
Status: Institution Denied
USPTO PTAB Trial 2016-06-29
IPR2016-01326

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01316

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Terminated-Settled
U.S. District Court 2017-12-14
1:17-cv-01795

AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC

Asserted Patent
Status: DED
U.S. District Court 2016-08-05
1:16-cv-00669

AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC

Asserted Patent
Status: DED
U.S. District Court 2014-06-03
1:14-cv-03547

ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.

Asserted Patent
Status: NJD
U.S. District Court 2010-01-07
1:10-cv-00018

AstraZeneca Pharmaceuticals LP v. Teva Parenteral Medicines Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

200
16

Notice of Refund Paper

2017-01-30 FILING PARTY: BOARD
15

Request for Refund of Post-Institution Fees Paper

2017-01-17 FILING PARTY: PETITIONER
14

Termination - Settled Before Institution Paper

2017-01-10 FILING PARTY: BOARD
11

Motion to Dismiss Paper

2017-01-09 FILING PARTY: PETITIONER
13

Motion to Treat Settlement as Confidential Paper

2017-01-09 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc